Camostat Mesylate is the mesylate salt form of camostat, an orally bioavailable, synthetic serine protease inhibitor, with anti-inflammatory, antifibrotic, and potential antiviral activities
camostat may inhibit the activity of transmembrane protease, serine 2 (TMPRSS2), a host cell serine protease that mediates viral cell entry for influenza virus and coronavirus, thereby inhibiting viral infection and replication.
Intermediate | CAS No's | API/End Use | Status | Purity |
4-Guanidinobenzoic Acid | 16060-65-4 | Camostat mesylate | Under development | NLT 97.5% |
4- Guanidinobenzoic Acid HCl | 42823-46-1 | Camostat mesylate | Under development | NLT 99% |
4-Hydroxy Benzeneacetic Acid2-(Dimethylamino)-2-oxoethyl Ester | 59721-16-3 | Camostat mesylate | Under development | NLT 98% |
Minimum Order Quantity | 100 Gram |
Cas No | 59721-16-3, 16060-65-4, 42823-46-1 |
Usage/Application | Commerical |
Packaging Size | Standard HDPE drums |
Manufacturer | AR Life Sciences Pvt Ltd. |
Form | Powder |